immunotherapy

209 проекта

H2020Индивидуална стипендия2015–2017Дания

MatrixMacrophages · Matrix degrading macrophages in cancer growth and invasion

H2020Индивидуална стипендия2015–2017Нидерландия

CR-PHAGOCYTOSIS · Complement-mediated phagocytosis in neutrophils

H2020Индивидуална стипендия2015–2017Белгия

ImmunoFarm · IgA-based oral therapy for protection of piglets against infection with enterotoxigenic E. coli.

H2020Индивидуална стипендия2015–2017Нидерландия

CARiPSCTcells · Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application

2 партньори

H2020Индивидуална стипендия2015–2018Обединеното кралство

WORMTUMORS · Worm power: Can helminths modify the development of colorectal cancer?

2 партньори · 2 държави

H2020Индивидуална стипендия2015–2017Обединеното кралство

DC cancer · Development and immunological control of dendritic cell cancer

2 партньори

H2020Индивидуална стипендия2015–2017Обединеното кралство

Tolltum · Role, regulation and targeting of nucleic acid-sensing TLRs within the tumour microenvironment

H2020Докторантска мрежа2015–2018Испания

IMMUNOSHAPE · Development of Selective Carbohydrate Immunomodulators Targeting C-type Lectin Receptors on Antigen Presenting Cells

16 партньори · 6 държави

H2020Докторантска мрежа2015–2018Италия

TOLLerant · Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach.

10 партньори · 5 държави

FP7Индивидуална стипендия2015–2017Германия

HIV-NOPA · Assessment of functional immune responses of HIV infected individuals without protective HLA-B alleles

FP7Индивидуална стипендия2014–2016Ирландия

RA AND GD T CELLS · The effect of retinoic acid on the fate of γδ T cells

FP7Реинтеграция2013–2017Испания

PRR IN IMMUNOTHERAPY · COMBINATIONAL USE OF INNATE IMMUNE RECEPTORS FOR CANCER IMMUNOTHERAPY

FP7Обмен на изследователи2013–2016Австрия

MODICELL · Targeted Modulation of Immune-System Responses in Cell Therapies

5 партньори · 3 държави

FP7Реинтеграция2012–2016Италия

STEMIMMUNE · Improving adoptive T cell transfer immunotherapy for cancer with T memory stem cells

FP7Реинтеграция2012–2016Франция

T9CAN · Transcriptional regulation of IL-9-producing CD4 T cells: use in cancer immunotherapy

FP7Индивидуална стипендия2011–2013Франция

3ITD · Impact of IL-7 and IFNa on nTreg development

FP7Реинтеграция2010–2014Чехия

GCPII_SYSTEM · Design and development of novel reagents, tools, and techniques targeting human glutamate carboxypeptidases II and III

FP7Реинтеграция2010–2012Гърция

NILTHERA · Novel Interleukins for immunotherapy of Asthma

FP7Реинтеграция2009–2013Швеция

CHEMO-IMMUNE THERAPY · A translational approach evaluating novel strategies using chemotherapy to enhance immune-mediated anti-tumor activity

FP7Индивидуална стипендия2008–2011Франция

NK-APC-TREG X-TALK · Cross-talk between NK, APC and regulatory T cells

FP7Индивидуална стипендия2008–2010Швеция

GIFT · Graft engineering to improve allogeneic stem cell transplantation

FP6Индивидуална стипендия2007–2009Гърция

IMMUNOEPIGENETICS · Anti-tumour CD8 immunity influenced by epigenetic alterations

FP6Индивидуална стипендия2006–2008Швейцария

LY49-AUTOIMMUNITY · Regulation of immune responses and autoimmunity by activating and inhibitory NK receptors expressed by T lymphocytes: role of ITAM versus ITIM signal balance

FP6Докторантска мрежа2006–2009Австрия

NK DEFENSE AND THERAPY · Natural killer cell-mediated anti-viral and anti-tumour defence and therapy: Integrated research training in molecular medicine, bioinformatics and issues of patent application and the SME biotech business

12 партньори · 7 държави